TF
NGVT icon

Tompkins Financial’s Ingevity NGVT Stock Holding History

Tompkins Financial’s Portfolio NGVT Stock Details NGVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,500
Closed -$65.6K – 612
2024
Q2 		$65.6K Hold
1,500
– – 0.01% 319
2024
Q1 		$71.5K Hold
1,500
– – 0.01% 317
2023
Q4 		$70.8K Hold
1,500
– – 0.01% 312
2023
Q3 		$71.4K Hold
1,500
– – 0.01% 293
2023
Q2 		$87.2K Hold
1,500
– – 0.01% 279
2023
Q1 		$107K Hold
1,500
– – 0.02% 251
2022
Q4 		$106K Hold
1,500
– – 0.02% 253
2022
Q3 		$91K Hold
1,500
– – 0.02% 270
2022
Q2 		$95K Hold
1,500
– – 0.02% 277
2022
Q1 		$96K Buy
+1,500
New +$100K 0.01% 288

Other funds holding NGVT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Tompkins Financial's NGVT Position: Q3 2024 in Review

Tompkins Financial sold out of Ingevity (NGVT) in Q3 2024, closing a stake of 1,500 shares — an estimated $65.6K sold.

Tompkins Financial first reported a position in NGVT in Q1 2022 and held it in 10 quarters. The position peaked at $107K in Q1 2023. 261 funds tracked by Wall St. Rank hold NGVT as of Q3 2024.

  • Tompkins Financial reported no remaining Ingevity position as of Q3 2024 after selling out during the quarter.
  • Tompkins Financial sold 1,500 Ingevity shares in Q3 2024, an estimated $65.6K.
  • Tompkins Financial first reported a position in Ingevity in Q1 2022 and held it in 10 quarters.
  • Tompkins Financial's Ingevity position peaked at $107K in Q1 2023.
  • 261 funds tracked by Wall St. Rank held Ingevity as of Q3 2024.

Based on Tompkins Financial's 13F filing for Q3 2024, filed 1 Nov 2024.